| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 09/07/2011 | CN1817882B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2011 | CA2459757C Combination |
| 08/16/2011 | US7998478 Pharmaceutical composition for treating immune diseases |
| 08/10/2011 | EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
| 08/09/2011 | CA2334941C Tnf-derived peptides for use in treating oedema |
| 07/27/2011 | EP1125585B1 Treatment of graft-versus-host disease targeting ailim |
| 07/20/2011 | EP1317279B1 Vaccine against streptococcus pneumoniae |
| 07/20/2011 | CN102125557A Use of flibanserin in the treatment of sexual disorders |
| 07/19/2011 | US7982037 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3 |
| 07/19/2011 | CA2448561C Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
| 07/12/2011 | US7977337 Quinoline derivatives and their use as 5-HT6 ligands |
| 07/12/2011 | CA2524394C Novel benzodiazepine compounds, compositions and uses thereof |
| 07/12/2011 | CA2516699C Hiv replication inhibiting pyrimidines and triazines |
| 07/06/2011 | EP2340833A2 Controlled release oxycodone compositions |
| 07/06/2011 | CN101357915B Diazabicyclic central nervous system active agents |
| 06/30/2011 | US20110158986 Humanized antibodies that sequester amyloid beta peptide |
| 06/29/2011 | EP1838257B1 Component for forming a seal around an opening in the skin |
| 06/29/2011 | CN101049502B Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/28/2011 | CA2467672C Chemokine receptor antagonists and methods of use therefor |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/16/2011 | US20110144008 Peptide agonists of glp-1 activity |
| 06/15/2011 | EP2332962A1 Cyclopenta[g]quinazoline compounds for use in the treatment of inflammatory or allergic conditions |
| 06/15/2011 | EP2332540A1 Administration of ranolazine for the treatment of diabetes |
| 06/08/2011 | EP2330129A2 Anti-TNF antibodies, compositions, methods and uses |
| 06/02/2011 | US20110130570 Novel Form of S-Omeprazole |
| 06/01/2011 | CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
| 05/25/2011 | CN101062037B Process for their preparation of thioxanthine derivatives, their use |
| 05/18/2011 | EP2322513A2 Intermediates |
| 05/18/2011 | EP2322210A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 05/18/2011 | CN102058597A Use of flibanserin in the treatment of sexual disorders |
| 05/17/2011 | US7943616 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders |
| 05/17/2011 | US7943153 Vaccines for Mycoplasma bovis and methods of use |
| 05/17/2011 | CA2688934C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 05/17/2011 | CA2470365C 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
| 05/11/2011 | EP2319516A1 Compounds for treating inflammatory and autoimmune disorders |
| 05/11/2011 | CN101254302B Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 04/27/2011 | EP2314313A1 Vaccine against streptococcus pneumoniae |
| 04/27/2011 | CN1810802B 3-substituted-4-pyrimidone derivatives |
| 04/20/2011 | EP2311850A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/20/2011 | EP2311825A1 Pyrimidineamines as angiogenesis modulators |
| 04/20/2011 | EP1603887B1 Hiv replication inhibiting indane substituted pyrimidines |
| 04/14/2011 | US20110086046 Treatment of MS with goat serum |
| 04/06/2011 | EP2305298A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP2305297A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP2305267A2 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 04/05/2011 | CA2474479C Composition for inhalation |
| 03/31/2011 | US20110077266 Diamine Derivatives |
| 03/30/2011 | EP1517710B1 Pegylated factor vii glycoforms |
| 03/29/2011 | US7915254 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 03/29/2011 | US7915234 Pharmaceutically active uridine esters |
| 03/29/2011 | CA2468715C Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 03/22/2011 | US7910589 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/17/2011 | US20110065736 Quinazoline derivatives as vegf inhibitors |
| 03/16/2011 | EP1326633B1 Composition comprising immunogenic microparticles |
| 03/15/2011 | CA2432000C Pyrimidineamines as angiogenesis modulators |
| 03/15/2011 | CA2426921C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/09/2011 | CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 03/09/2011 | CN101297969B Combinations of the peroxisome proliferator-activated receptor (PPAR) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications |
| 03/08/2011 | CA2689051C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/02/2011 | EP2289876A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
| 03/02/2011 | EP2289517A2 Controlled release oxycodone compositions |
| 03/02/2011 | EP1423101B1 Use of a plaster for the treatment of onychomycoses |
| 03/01/2011 | CA2348954C A pharmaceutical composition for treating immune diseases |
| 02/23/2011 | EP2286818A1 Fulvestrant formulation |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/22/2011 | US7892545 Humanized antibodies that sequester amyloid beta peptide |
| 02/17/2011 | US20110039802 Npy y5 antagonist |
| 02/15/2011 | CA2689052C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/15/2011 | CA2455453C Taxol enhancer compounds |
| 02/08/2011 | CA2456604C Pharmaceutical composition comprising lumiracoxib |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/01/2011 | CA2688915C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 02/01/2011 | CA2454120C Taxol enhancer compounds |
| 01/26/2011 | EP2277535A2 Vaccine |
| 01/25/2011 | CA2469594C Crystal of bicalutamide and production method thereof |
| 01/25/2011 | CA2368849C Process for preparing amine platinum complexes |
| 01/19/2011 | EP2275416A1 Biologically active methylene blue derivatives |
| 01/19/2011 | CN101947218A Method for modulating calcium ion-release-activated calcium ion channels |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/13/2011 | US20110008419 Vaccine Against Streptococcus Pneumoniae |
| 01/12/2011 | EP2272516A2 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 01/12/2011 | CN101612401B Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/11/2011 | CA2451678C Azaindoles |
| 01/11/2011 | CA2387095C Compound with growth hormone releasing properties |
| 01/06/2011 | US20110002953 Use of immidazoquinolinamines as adjuvants in dna vaccination |
| 01/06/2011 | US20110002894 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 01/05/2011 | EP2269604A1 Treatment of solid tumours with rapamycin derivatives |
| 01/05/2011 | EP2269603A1 Treatment of solid tumours with rapamycin derivatives |
| 01/04/2011 | US7863284 such as N-{N-{4-[N-(2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamic acid, used for aiding regression and palliation of ovarian cancer; antiproliferative agents |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 12/29/2010 | EP2266573A1 Fulvestrant formulation |
| 12/29/2010 | CN1926132B Pyrazole compounds useful as protein kinase inhibitors |
| 12/29/2010 | CN101928262A Biologically active methylene blue derivatives |
| 12/28/2010 | US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them |